Aeternum Health Q2 FY26 operating loss widens to $270,879; revenue remains no revenue

AETN•2026-08-19

Cash position, liquidity and outlook

Cash totaled USD 702,809 at June 30, 2026, with working capital of about USD 1.8 million.

The company flagged substantial doubt about going concern and expects additional financing as it pivots to critical minerals and longevity-focused development.

Quarterly results and discontinued business gain

Aeternum Health posted a GAAP operating loss from continuing operations of USD 270,879 for the quarter ended June 30, 2026.

No revenue from continuing operations was reported for the quarter, unchanged from the year-earlier period.

Results included a USD 2.01 million gain on disposal of the discontinued Shorepower business, alongside a USD 13,898 loss from discontinued operations.

Sources

Aeternum Health Q2 FY26 operating loss widens to $270,879; revenue remains no revenue

Sec

Aeternum Health Q2 FY26 operating loss widens to $270,879; revenue remains no revenue

Cash position, liquidity and outlook

Quarterly results and discontinued business gain

Related News

Cullinan says REZILIENT3 interim data for zipalertinib plus chemotherapy in EGFR exon 20 NSCLC lands IASLC WCLC 2026 Presidential Symposium slot

Global Markets-Global yields fall after US Treasury boosts debt buybacks

Nasdaq Trade Halt <CDTG.O> Volatility Trading Pause at 12:07 PM

Sources

Aeternum Health Q2 FY26 operating loss widens to $270,879; revenue remains no revenue

Dolphin Entertainment CEO William O'Dowd IV buys $4,911.8 in common shares

Maine governor says NextEra-Dominion merger will limit competition, raise energy cost concerns